SCHEMBL692500

SCHEMBL692500

O=C(C=Cc1ccccc1)N1CCCCC1

nearest known ligand 0.87

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.87
KMT2A Q03164 3/20 0.87
RAB9A P51151 5/20 0.71
POLB P06746 2/20 0.71
ALDH1A1 P00352 7/20 0.65
SMN1; SMN2 Q16637 7/20 0.65
MAPT P10636 5/20 0.65
NPC1 O15118 4/20 0.65
HPGD P15428 2/20 0.65
ME2 P23368 1/20 0.61
ME1 P48163 1/20 0.61
ME3 Q16798 1/20 0.61
LMNA P02545 3/20 0.61
TP53 P04637 1/20 0.61
AR P10275 1/20 0.60
L3MBTL1 Q9Y468 1/20 0.60
GAA P10253 1/20 0.60
PLIN1 O60240 1/20 0.57
CYP1A2 P05177 1/20 0.57
CYP2D6 P10635 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL692605 1.00 MEN1 (0.87) MEN1KMT2ARAB9APOLBALDH1A1
SCHEMBL692499 1.00 MEN1 (0.87) MEN1KMT2ARAB9APOLBALDH1A1
SCHEMBL28112899 1.00 MEN1 (0.87) MEN1KMT2ARAB9APOLBALDH1A1
SCHEMBL692258 0.98 MEN1 (0.90) MEN1KMT2ARAB9APOLBALDH1A1
SCHEMBL692257 0.98 MEN1 (0.90) MEN1KMT2ARAB9APOLBALDH1A1
SCHEMBL16599448 0.91 KMT2A (0.89) MEN1KMT2ARAB9APOLBALDH1A1
SCHEMBL4456981 0.91 KMT2A (0.89) MEN1KMT2ARAB9APOLBALDH1A1
SCHEMBL16599447 0.91 KMT2A (0.89) MEN1KMT2ARAB9APOLBALDH1A1
SCHEMBL29738475 0.88 KMT2A (0.69) MEN1KMT2ARAB9APOLBALDH1A1
SCHEMBL30853516 0.88 KMT2A (0.69) MEN1KMT2ARAB9APOLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2710892-B1 Use of sarmentine and its analogs for controlling weeds MARRONE BIO INNOVATIONS INC (US) 2016-12-14 EP claimed
EP-2918271-A1 Aromatic alkenoic acid derivatives as aroma compounds Symrise AG (DE) 2015-09-16 EP claimed
EP-2710892-A2 Use of sarmentine and its analogs for controlling plant pests Marrone Bio Innovations, Inc. (US) 2014-03-26 EP claimed
US-20130196013-A1 CHEMICAL AND BIOLOGICAL AGENTS FOR THE CONTROL OF MOLLUSCS MARRONE BIO INNOVATIONS, INC. (US) 2013-08-01 US claimed
EP-2601840-A2 Chemical and biological agents for the control of molluscs Marrone Bio Innovations, Inc. (US) 2013-06-12 EP claimed
US-20130121978-A1 CHEMICAL AND BIOLOGICAL AGENTS FOR THE CONTROL OF MOLLUSCS MARRONE BIO INNOVATIONS, INC. (US) 2013-05-16 US claimed
EP-2421375-A2 CHEMICAL AND BIOLOGICAL AGENTS FOR THE CONTROL OF MOLLUSCS Marrone Bio Innovations, Inc. (US) 2012-02-29 EP claimed
WO-2010123894-A2 CHEMICAL AND BIOLOGICAL AGENTS FOR THE CONTROL OF MOLLUSCS MARRONE BIO INNOVATIONS, INC. (US) 2010-10-28 WO claimed
US-20100266717-A1 CHEMICAL AND BIOLOGICAL AGENTS FOR THE CONTROL OF MOLLUSCS MARRONE BIO INNOVATIONS, INC. (US) 2010-10-21 US claimed
CN-101808635-A Use of piperine and derivatives thereof for the therapy of neurological conditions SYGNIS BIOSCIENCE GMBH & CO KG 2010-08-18 CN claimed
US-20100179130-A1 USE OF PIPERINE AND DERIVATIVES THEREOF FOR THE THERAPY OF NEUROLOGICAL CONDITIONS SYNGIS Bioscience GmbH & Co. KG (DE) 2010-07-15 US claimed
EP-2170320-A1 USE OF PIPERINE AND DERIVATIVES THEREOF FOR THE THERAPY OF NEUROLOGICAL CONDITIONS Sygnis Bioscience GmbH & Co. KG (DE) 2010-04-07 EP claimed
WO-2009004071-A1 USE OF PIPERINE AND DERIVATIVES THEREOF FOR THE THERAPY OF NEUROLOGICAL CONDITIONS SYGNIS BIOSCIENCE GMBH & CO. KG (DE) 2009-01-08 WO claimed
EP-2011495-A1 Use of piperine and derivatives thereof for the therapy of neurological conditions Sygnis Bioscience GmbH & Co. KG (DE) 2009-01-07 EP claimed
US-20240336869-A1 MICROWAVE ASSISTED EXTRACTION OF ESSENTIAL OILS FROM PLANT BIOMASS FIRMENICH SA (CH) 2024-10-10 US disclosed
US-12054692-B2 Microwave assisted extraction of essential oils from plant biomass FIRMENICH SA (CH) 2024-08-06 US disclosed
CN-116444370-A Preparation method of alpha, beta-unsaturated carboxylic acid derivative 大连理工常熟研究院有限公司 2023-07-18 CN disclosed
EP-0157399-B1 4-(5H-Dibenzo[a,d]cyclohepten-5-yl) piperidine compounds MERCK & CO. INC. (US) 1989-08-16 EP disclosed
US-4758577-A 4-(5H-dibenzo[a,d]cyclohepten-5-yl)piperidine compounds for treating cardiovascular disorders MERCK & CO., INC. (US) 1988-07-19 US disclosed
EP-0157399-A2 4-(5H-Dibenzo[a,d]cyclohepten-5-yl) piperidine compounds MERCK & CO. INC. (US) 1985-10-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100266717-A1 CHEMICAL AND BIOLOGICAL AGENTS FOR THE CONTROL OF MOLLUSCS ACHE, POLI, POLL MEN1 3759/4885KMT2A 1501/4885RAB9A 448/4885
US-20130196013-A1 CHEMICAL AND BIOLOGICAL AGENTS FOR THE CONTROL OF MOLLUSCS ACHE, POLI, POLL MEN1 3759/4885KMT2A 1501/4885RAB9A 448/4885
US-20100179130-A1 USE OF PIPERINE AND DERIVATIVES THEREOF FOR THE THERAPY OF NEUROLOGICAL CONDITIONS PRPH, BDNF, GAP43 MEN1 3003/4885KMT2A 1722/4885RAB9A 803/4885
US-20130121978-A1 CHEMICAL AND BIOLOGICAL AGENTS FOR THE CONTROL OF MOLLUSCS ACHE, POLI, POLL MEN1 3759/4885KMT2A 1501/4885RAB9A 448/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.